Fibrates Therapy

Fibrates Therapy is a pharmacological treatment modality that belongs to the class of lipid-lowering interventions and is distinguished by the use of peroxisome proliferator-activated receptor alpha (PPAR-α) agonists to modulate immune and metabolic pathways in the management of autoimmune liver diseases.

90

Publications

4.9K

Citations

513

Authors

221

Institutions

Publications per year

2017–2026

17

Variants

Fibrate Therapy

Publications

90

1–5 of 90

Authors

513

  1. BS
    Bart Staels

    Institut Pasteur de Lille, France

    12 publications · 1.5K citations

    12

    h-index

  2. JF
    Jean‐Charles Fruchart

    Institut Pasteur de Lille, France

    6 publications · 605 citations

    6

    h-index

  3. MK
    Maaike Kockx

    Concord Repatriation General Hospital, Australia

    6 publications · 438 citations

    6

    h-index

  4. TK
    Teake Kooistra

    Netherlands Organisation for Applied Scientific Research, Netherlands

    5 publications · 399 citations

    5

    h-index

  5. FJ
    Frank J. Gonzalez

    National Cancer Institute, United States

    4 publications · 232 citations

    4

    h-index

1–5 of 513

Venues

  1. PubMed

    Repository · 9 publications · 241 citations

    9

    h-index

  2. Journal of Biological Chemistry

    JBC · 5 publications · 622 citations

    5

    h-index

  3. Journal of Lipid Research

    JLR · 3 publications · 263 citations

    3

    h-index

  4. Journal of Medicinal Chemistry

    3 publications · 211 citations

    3

    h-index

  5. Thrombosis and Haemostasis

    3 publications · 82 citations

    3

    h-index

1–5